(1)
Dusp6 Inhibits Epithelial-Mesenchymal Transition in Endometrial Adenocarcinoma via ERK Signaling Pathway: Dusp6 Inhibits EMT in EAC via Regulating ERK Pathway. Radiol Oncol 2019, 53 (3), 307-315.